Key result
High ePWV lacks independent clinical associations in treated hypertensives after adjusting for age and SBP.
Why the study?
The study investigated the prevalence and correlates of arterial stiffness in treated hypertension using oscillometric pulse wave analysis during 24-h ambulatory blood pressure monitoring.
What is the prevalence and what are the independent clinical correlates of arterial stiffness (ePWV) in patients with treated hypertension?
Cross-Sectional (n=131)
No
What is the prevalence and what are the independent clinical correlates of arterial stiffness (ePWV) in patients with treated hypertension?
Estimated pulse wave velocity derived from oscillometric ABPM is highly dependent on age and SBP, and after adjusting for these inputs, it does not exhibit independent associations with most clinical parameters, suggesting it should be viewed as an integrated derivative rather than a separate physiological measure.
ePWV from ABPM should be viewed as an integrated derivative of age and SBP rather than an independent parameter; leaves open its added value in treated hypertension.
Background We investigated the prevalence and correlates of arterial stiffness in treated hypertension using oscillometric pulse wave analysis during 24‐h ambulatory blood pressure monitoring (ABPM). Methods In this single‐center cross‐sectional study, 131 patients (median age 51.0 years, range 17.0–86.0; 54.2% female) underwent 24‐h ABPM. Measurements included 24‐h, daytime, and night‐time SBP, DBP, MAP, pulse pressure, dipping status, and estimated pulse wave velocity (ePWV) derived by the Mobil‐O‐Graph (ARCSolver; age/SBP‐dependent). Results High ePWV (> 9 m/s) was present in 16.8% of patients. Compared with low/moderate ePWV, the high‐ePWV subgroup was older ( p < 0.001) and had higher FPG ( p < 0.001), higher creatinine and lower eGFR (both p < 0.001), greater proteinuria ( p = 0.006), and a lower frequency of systolic dipper status ( p = 0.033). In simple correlations, 24‐h ePWV was correlated positively with 24‐h, daytime, and night‐time values of DBP, MAP, and pulse pressure, BMI, FPG, creatinine, uric acid, and proteinuria, and negatively with systolic dipping, diastolic dipping, albumin, and eGFR. However, after adjusting for age, age 2 , and 24‐h SBP, the partial correlation analysis revealed that ePWV was negatively correlated only with FPG ( r = −0.216, p = 0.014) and hsCRP ( r = −0.220, p = 0.031) and positively correlated only with total cholesterol ( r = 0.243, p = 0.043) and LDL ( r = 0.359, p = 0.004). Conclusion Elevated ePWV identifies a high‐risk phenotype in treated hypertension, characterized by advanced age and renal impairment. However, these associations appear intrinsic to the algorithm’s reliance on age and SBP. After adjusting for these inputs, ePWV did not exhibit independent associations with clinical parameters, suggesting it should be viewed as an integrated derivative of age and blood pressure rather than a separate physiological measure. ePWV values should be interpreted with caution, recognizing their inherent dependence on algorithmic inputs.
No takes yet. Share an insight, caveat, or question.
TÜFEKÇİ et al. (2026) conducted a cross-sectional in treated hypertension (n=131). 24-h ambulatory blood pressure monitoring with oscillometric pulse wave analysis was evaluated on Prevalence of high estimated pulse wave velocity (> 9 m/s). High estimated pulse wave velocity (>9 m/s) was present in 16.8% of treated hypertensive patients, but after adjusting for age and SBP, it lacked independent associations with clinical parameters.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: